Associations between immune-suppressive and stimulating drugs and novel COVID-19—a systematic review of current evidence
Review
[키워드] acute respiratory syndrome
adverse events
anti-CD20
auto-immune disease
blockade
blockers
Cancer
Chemotherapy
coronavirus
COVID-19
COVID-19 pandemic
COVID-19 patient
Cytokines
Cytotoxic chemotherapy
drug
drugs
Effect
elevated
Evidence
higher risk
host immunity
IL-1
IL-6
IL-6 inhibitor
immune modulation
Immune suppression
Impact
In vitro studies
induce
inhibitor
inhibitors
Jak
JAK-STAT pathway
Janus kinase
Kinase inhibitor
less
low-dose
methotrexate
modulation
Necrosis
non-steroidal anti-inflammatory drug
NSAIDS
OVID
Patient
patients
patients with COVID-19
Prednisolone
pro-inflammatory cytokine
pulmonary complications
respiratory diseases
Result
secretion
severity
shown
Steroids
systematic review
target
TNFα
treated
Treatment
[DOI] 10.3332/ecancer.2020.1022 PMC 바로가기 [Article Type] Review
[DOI] 10.3332/ecancer.2020.1022 PMC 바로가기 [Article Type] Review